Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence

Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence

AbstractLatent tuberculosis infection (LTBI) and human immunodeficiency virus (HIV)-coinfection are challenges in the control of tuberculosis transmission. We aimed to assess and summarize evidence available in the literature regarding the treatment of LTBI in both the general and HIV-positive popul...

Full description

Bibliographic Details
Main Authors: Júlia Souza Vidal, Marcus Tolentino Silva, Mauro Niskier Sanchez
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2015-10-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Latent tuberculosis
Evidence-based practice
Decision making
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000500507&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822015000500507&lng=en&tlng=en

Similar Items